Free Trial

Chromocell Therapeutics (CHRO) Stock Trends and Sentiment

$1.46
+0.17 (+13.18%)
(As of 07/26/2024 ET)

Media Mentions Over Time



View Trending Media Stocks

MarketBeat Searches Over Time

Page Views Over Time



Recieve Chromocell Therapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for CHRO and its competitors with MarketBeat's FREE daily newsletter.

CHRO Social Media Mentions

Related Companies and Tools

This page (NYSE:CHRO) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners